| 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|
| Profit/loss | 586,1 k € | +119.4% | 267,2 k € | +277.7% | 70,7 k € | +714.8% | -11,5 k € | |
| Equity | 1,2 M € | +90.0% | 651,2 k € | +69.6% | 384,0 k € | +22.6% | 313,2 k € | |
| Gross margin | — | — | — | — | ||||
| Staff | 48,9 | 49,5 | 52,5 | 46,8 | ||||
Key indicators
| Unit no. | Name | Location |
|---|---|---|
| 2183566703 | Keyrus Biopharma | Drève Richelle 161 box 18, 1410 Waterloo |
Public limited company · Waterloo · incorporated on 30/11/2009 · 48,9 ETP
Public limited company rentable et capitalisée. Trésorerie en hausse (+5.5 %).
Source: filing of 17/06/2025
7-day free trial, no credit card required.
Source: Belgian Official Gazette